News from the Royal College of Pathologists

Modernising Pathology

The following letter is the response by the college to the request from Lord Warner for Pathology Services to be reviewed by Lord Carter.


President's Office

Telephone: 020 7451 6710

Fax: 020 7451 6702

e-mail: james.underwood@rcpath.org

Lord Warner of Brockley

Minister of State for NHS Delivery

Department of Health

Richmond House

79 Whitehall

London SW1A 2NS

 

21 September 2005

 

 

 

 

 

Modernising Pathology: Building a Service Responsive to Patients

 

I am writing to affirm the Royal College of Pathologists' eagerness to assist the independent review of pathology services in England to be conducted by Lord Carter of Coles and the Pathology Service Review Panel. The review is one element of Modernising Pathology: Building a Service Responsive to Patients , published by the Department of Health on 9 September and discussed by the College's Council at its meeting on 15 September.

 

The College's Pathology Modernisation Reference Panel will be the principal interface between the College and the independent review. It comprises representatives of the major pathology specialties together with the directors of training and of professional standards and, of course, a lay member to represent patients' interests. Before the independent review was announced, I had already instigated a survey of the scale and scope of pathology modernisation within each of College's eight regions in England. The results of this survey will be available in October; I am sure that the findings will be of interest to Lord Carter and the Pathology Service Review Panel. Indeed, I hope that the College's Pathology Modernisation Reference Panel will be able to meet Lord Carter in the near future. In addition to copying this letter to him, I will be writing separately to offer the College's input to the review and to invite him to meet with the Pathology Modernisation Reference Panel.

 

Although we realise that it is not a consultation document, I thought it might be helpful at this stage to set out the College's initial comments on Modernising Pathology: Building a Service Responsive to Patients . We hope that the following points will be explored further by Lord Carter and his independent review panel:

•  The College welcomes the patient focus of the government's vision for pathology service. Indeed, this accords fully with the delivery of pathology as a clinical service. The clinical aspects includes not only clinical accountability for the reliability of individual pathology investigations (the Department of Health estimates that 70% of diagnoses in the NHS rely on pathology tests), but also the consultative clinical involvement in the pre-analytical and post-analytical phases. While the extent of clinical involvement varies with the indications for and complexity of the investigation, this vitally important dimension is a remarkable omission from “The Pathology Patient Pathway” (Annex B, Figure 1, page 23).
•  In the interests of patient welfare and safety, the College emphasises the imperatives of laboratory accreditation and quality assurance. The College applauded John Hutton's ministerial statement (June 2003) that pathology services to NHS patients should be registered with an accreditation scheme and, on behalf of patients, we hope that the government will reaffirm this. It is notable that the lay representatives on College Council give primacy to the quality of pathology investigations rather than, within reason, to issues of timeliness and convenience. This is pertinent particularly to the involvement of “innovative new providers … in non-traditional settings” (paragraph 2.7).
•  We note that mortuary services are mentioned in paragraph 2.9. The College will be apprising the Pathology Service Review Panel of the other wider integral functions of pathology services such as hospital infection control, multidisciplinary involvement in cancer diagnosis and treatment, population screening, direct clinical care, etc.
•  Pathology services are reliant on devices and technologies for much of their analytical, interpretive and consultative work. Therefore, the Health Industries Task Force report Better health through partnership: a programme for action (cited in paragraph 3.3) is of considerable relevance. The College supports strongly an evidence-based approach to the introduction of new technologies, with patient outcomes as the ultimate test of their effectiveness. The involvement of pathology specialists is vital. Even with existing technologies, we believe there is significant inappropriate use and, with point-of-care testing, a risk of misinterpretation and of fragmentation of patient data which could be detrimental.
•  We hope that the government's commitment to increasing the independent sector's involvement in NHS pathology services will be complemented by a commitment to expanding our capacity to train the next generation of the skilled pathology workforce — biomedical scientists, clinical scientists and medical pathologists. The College recommends that consideration of “capacity” in the terms of reference of the Pathology Service Review Panel (paragraph 4.3) should take training and future workforce supply into account.
•  The College supports and exerts, within its remit, national leadership in pathology modernisation, but recognises that the configuration of local services involves local leadership, local decisions and local implementation. To safeguard patient welfare and to ensure continuous improvement through audit and remedial actions, we recommend that independent and NHS providers of local pathology services for NHS patients should have management and operational relationships that permit seamless clinical governance.
•  Developments in primary care, notably the new GMS contract, have led to substantial increases in clinical biochemistry workloads. This, and a number of other issues at the interface between primary care and pathology services, were discussed last year with Dr David Colin-Thomé (National Director for Primary Care). The College welcomes the commitment (paragraph 2.10) to work with the National Primary Care Development Team; the College would be pleased to be a partner in this.

In conclusion, I emphasise the College's wish to be engaged fully in the independent review with a view to achieving high quality pathology services for current and future patients.

 

 

 

Professor Sir James Underwood

President.


Back to top